Tag: Notizia

Notizia

Articles

Read More

Notizia

Notizia, Pharma Consultant

Idera’s dermatomyositis drug missed primary endpoint in phase 2 Idera’s toll-like receptor (TLR) antagonist, IMO-8400, failed to...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Atara Biotherapeutics hires ex-Genentech SVP to lead its global R&D program Atara Biotherapeutics recently hired Dietmar Berger, M.D.,...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Anthera’s Sollpura flops after phase 3   Anthera cut free it’s flopped late-arrange Lilly castoff Sollpura (liprotamase), and now...

Read More

Notizia

Notizia

Rice University researchers tested CRISPR to cure sickle cell, now preparing for upcoming challenges A team of Researchers led by Rice...

Read More

NOTIZIA

Notizia, Pharma Consultant, Specialized Reports, Uncategorized

Regeneron/Sanofi’s PD-1 drug candidate will be tested with ISA’s HPV immunotherapy Regeneron and Sanofi’s PD-1 candidate cemiplimab...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant, Uncategorized

Positive Phase 2 data for Roche’s lymphoma ADC Roche’s antibody-drug conjugate for non-Hodgkin lymphoma polatuzumab has already...

Read More
Close